市場調查報告書
商品編碼
957600

生物植入的全球市場

Bioimplants

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球生物植入的市場規模在分析期間(2020年∼2027年)預計將以5.5%的年複合成長率增長,從2020年的918億美元到2027年達到1,334億美元。本報告分析市場區隔之一的心血管生物植入部門在分析期間結束前預測將以5.6%的年率增長,達到409億美元。

本報告提供全球生物植入市場的相關調查,提供市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Dentsply Sirona, Inc.
  • Invibio Ltd.
  • Johnson & Johnson
  • Medtronic PLC
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.

目錄

I. 簡介,調查手法,調查範圍

II. 摘要整理

  • 市場概要
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • Covid-19的影響和即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 簡介公司總數:46公司
目錄
Product Code: MCP10715

Abstract:

Global Bioimplants Market to Reach $133.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Bioimplants estimated at US$91.8 Billion in the year 2020, is projected to reach a revised size of US$133.4 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027. Cardiovascular Bioimplants, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$40.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Orthopedic Bioimplants segment is readjusted to a revised 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $27.1 Billion, While China is Forecast to Grow at 5.1% CAGR

The Bioimplants market in the U.S. is estimated at US$27.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$23.5 Billion by the year 2027 trailing a CAGR of 5.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Dental Bioimplants Segment to Record 6.4% CAGR

In the global Dental Bioimplants segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$7.8 Billion in the year 2020 will reach a projected size of US$12.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$15.3 Billion by the year 2027.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Dentsply Sirona, Inc.
  • Invibio Ltd.
  • Johnson & Johnson
  • Medtronic PLC
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bioimplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Cardiovascular Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Cardiovascular Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cardiovascular Bioimplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Orthopedic Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Orthopedic Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Orthopedic Bioimplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Dental Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Dental Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Dental Bioimplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Spinal Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Spinal Bioimplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Spinal Bioimplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 19: USA Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: USA Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: USA 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 22: Canada Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 23: Canada Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: Canada 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 25: Japan Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Japan Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: Japan 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 28: China Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: China Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: China 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 31: Europe Current & Future Analysis for Bioimplants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe Historic Review for Bioimplants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Europe 15-Year Perspective for Bioimplants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 34: Europe Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Europe Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Europe 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 37: France Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: France Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: France 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 40: Germany Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Germany Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Germany 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 43: Italy Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Italy Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Italy 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 46: UK Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: UK Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: UK 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Rest of Europe Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Rest of Europe 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 52: Asia-Pacific Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Asia-Pacific Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Asia-Pacific 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 55: Rest of World Current & Future Analysis for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Rest of World Historic Review for Bioimplants by Segment - Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Rest of World 15-Year Perspective for Bioimplants by Segment - Percentage Breakdown of Value Sales for Cardiovascular Bioimplants, Orthopedic Bioimplants, Dental Bioimplants, Spinal Bioimplants and Other Segments for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46